How to improve the cure rate of cervical precancerous lesions

How to improve the cure rate of cervical precancerous lesions? Many patients want to know this question. Once diagnosed with cervical precancerous lesions, it is necessary to pay more attention to it. But at the same time, we should also be careful not to be too nervous. We should despise it strategically and pay attention to it tactically. "Immediately check and treat, do a good job of reexamination and prevention can control it well.

When cervical precancerous lesions are detected, the treatment of cervical precancerous lesions is the most concerned issue for patients. According to research, CIN1 patients have a nearly 60% chance of natural reversal, so if the lesion is not too large, close follow-up or local physical therapy, such as electrocautery, laser and microwave therapy, is sufficient. This treatment only needs to be completed in the gynecological clinic and the treatment process is basically painless. CIN2/3 patients can be treated by local excision. Commonly used methods include loop electrosurgical excision procedure (LEEP) and cervical cone resection. By locally removing the lesion, the reproductive function is preserved and a satisfactory treatment effect can be achieved. Surgeries such as loop electrosurgical excision only need to be performed under local anesthesia and are completed in about 5 to 10 minutes. There may be vaginal discharge for a period of time after the operation, and the surgical wound will heal in 4 to 6 weeks. The couple can resume their sexual life 3 months after the operation.

Cervical precancerous lesions are not to be feared. Early detection and early treatment can even achieve a 100% cure rate. Experts recommend that women start cervical cancer screening at the age of 21 or after three years of sexual activity until the age of 65, and have a cervical cytology smear test once a year. Timely detection and diagnosis of cervical precancerous lesions and appropriate treatment can achieve the goal of preventing cervical cancer.